Targacept Announces Participation in Upcoming Conferences Needham Healthcare Conference 2013 Deutsche Bank dbAccess Healthcare Conference 2013 Jefferies Global Healthcare Conference 2013 Business Wire WINSTON-SALEM, N.C. -- April 22, 2013 Targacept, Inc. (NASDAQ: TRGT), a clinical-stage biopharmaceutical company developing novel NNR Therapeutics™, today announced that Dr. Stephen A. Hill, President and Chief Executive Officer, is scheduled to present at the following conferences: *12^th Annual Needham Healthcare Conference at the Westin Grand Central Hotel in New York, New York on Tuesday, April 30, 2013 at 12:10 p.m. Eastern Time. *38^th Annual Deutsche Bank dbAccess Healthcare Conference at the Westin Boston Waterfront in Boston, Massachusetts on Wednesday, May 29, 2013 at 11:20 a.m. Eastern Time. *Jefferies 2013 Global Healthcare Conference at the Grand Hyatt Hotel in New York, New York on Thursday, June 6, 2013 at 1:00 p.m. Eastern Time. Each presentation will be webcast and accessible from the Investor Relations page of Targacept’s website, www.targacept.com. To ensure a timely connection to any of the webcasts, it is recommended that users register at least 15 minutes prior to the scheduled start time. An archived version of each webcast will be available for replay on the Investor Calendar section of the Investor Relations page of Targacept’s website for at least two weeks following the corresponding event. About Targacept Targacept is developing a diverse pipeline of innovative NNR Therapeutics™ for difficult-to-treat diseases and disorders of the nervous system. NNR Therapeutics selectively modulate the activity of specific neuronal nicotinic receptors, unique proteins that regulate vital biological functions that are impaired in various disease states. Targacept’s clinical pipeline includes multiple Phase 2 product candidates, all representing first-in-class opportunities. Targacept leverages its scientific leadership and diverse pipeline to attract significant collaborations with global pharmaceutical companies. For more information, please visit www.targacept.com. TARGACEPT Building Health, Restoring Independence® Contact: Targacept, Inc. Alan Musso, 336-480-2186 SVP, Finance and Administration and CFO firstname.lastname@example.org or Linnden Communications Michelle Linn, 508-362-3087 email@example.com
Targacept Announces Participation in Upcoming Conferences
Press spacebar to pause and continue. Press esc to stop.